Why I posted that is because although that article hints at genetically oriented personalised medicine, the point isn't genetics, at least not of itself directly IMO.
The point is that medicine being personilised (however it's achieved) is by definition uniquely suited to the patient. CVac achieves that by training your anti bodies to recognize the cancer thus boosting your own immune system's ability to fight off and destroy thd cancer.
There may be some indirect genetics at play behind the scenes or there may not, but the concept is the same.
CVac is very worth while waiting for IMO.
Why I posted that is because although that article hints at...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |